Cross-institution positioning
Mar 26, 2026Reduction leaning. 2 reducing, 2 exited across 4 comparable institutions.
Source: Schedule 13 researchGENESCO INC
Latest stored close $36.51 as of Oct 9, 2026 View live quote ↗
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Reduction leaning. 2 reducing, 2 exited across 4 comparable institutions.
Source: Schedule 13 research1 increased/new, 1 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsOver the last 90 days, SEC-coded non-derivative P/S activity includes 2 purchases by 2 reporting owners and 0 sales by 0 reporting owners. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/54 non-amendment material events in the last 90 days; 1 capital-related filing/event (1 equity-related, 0 debt-related); Latest classified evidence: Employee-plan securities registration. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue -3.0% YoY; Net income +118.8% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 57% through its reported 52-week range; +2.1% over one year.
Source: Stored historical price seriesFiled Mar 26, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Collins Jonathan M. | POpen-market or private purchase | Common Stock | 295 | $33.84 | Direct | Sep 22, 2026 |
| Aug 3, 2026 | Collins Jonathan M. | AGrant, award, or other acquisition | Common Stock | 11.4K | $0.00 | Direct | Aug 4, 2026 |
| Jul 24, 2026 | MARSHALL THURGOOD JR | AGrant, award, or other acquisition | Common Stock | 3.9K | $0.00 | Direct | Jul 24, 2026 |
| Jul 24, 2026 | Lambros John F | AGrant, award, or other acquisition | Common Stock | 3.9K | $0.00 | Direct | Jul 24, 2026 |
| Jul 24, 2026 | MARTINEZ ANGEL R | AGrant, award, or other acquisition | Common Stock | 3.9K | $0.00 | Direct | Jul 24, 2026 |
| Jul 24, 2026 | Meixelsperger Mary E | AGrant, award, or other acquisition | Common Stock | 3.9K | $0.00 | Direct | Jul 24, 2026 |
| Jul 24, 2026 | Bojanowski Carolyn | AGrant, award, or other acquisition | Common Stock | 3.9K | $0.00 | Direct | Jul 24, 2026 |
| Jul 24, 2026 | Bilunas Matthew M | AGrant, award, or other acquisition | Common Stock | 3.9K | $0.00 | Direct | Jul 24, 2026 |
| Jul 24, 2026 | SANDFORT GREGORY A | AGrant, award, or other acquisition | Common Stock | 3.9K | $0.00 | Direct | Jul 24, 2026 |
| Jul 24, 2026 | Barsh Joanna | AGrant, award, or other acquisition | Common Stock | 3.9K | $0.00 | Direct | Jul 24, 2026 |
| Jul 9, 2026 | SANDFORT GREGORY A | POpen-market or private purchase | Common Stock | 3.0K | $33.80 | Indirect | Jul 13, 2026 |
| Jun 26, 2026 | Randolph Ashley Marie | FTax/price withholding or payment | Common Stock | 57 | $36.18 | Direct | Jul 2, 2026 |
| Jun 26, 2026 | Becker Scott E | FTax/price withholding or payment | Common Stock | 486 | $36.18 | Direct | Jun 29, 2026 |
| Jun 26, 2026 | Ewoldsen Daniel E | FTax/price withholding or payment | Common Stock | 373 | $36.18 | Direct | Jun 29, 2026 |
| Jun 26, 2026 | Desai Parag | FTax/price withholding or payment | Common Stock | 547 | $36.18 | Direct | Jun 29, 2026 |
| Jun 26, 2026 | VAUGHN MIMI ECKEL | FTax/price withholding or payment | Common Stock | 4.8K | $36.18 | Direct | Jun 29, 2026 |
| Apr 2, 2026 | Ewoldsen Daniel E | AGrant, award, or other acquisition | Common Stock | 7.7K | $0.00 | Direct | Apr 7, 2026 |
| Apr 2, 2026 | Becker Scott E | AGrant, award, or other acquisition | Common Stock | 9.9K | $0.00 | Direct | Apr 7, 2026 |
| Apr 2, 2026 | VAUGHN MIMI ECKEL | AGrant, award, or other acquisition | Common Stock | 74.8K | $0.00 | Direct | Apr 7, 2026 |
| Apr 2, 2026 | Gray Andrew | AGrant, award, or other acquisition | Common Stock | 376 | $0.00 | Direct | Apr 7, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Sep 10, 2026 | S-8 | — | Employee-plan securities registration | Equity | Filing |
| Sep 3, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Aug 6, 2026 | 8-K | 5.02, 7.01, 9.01 | Director or executive change; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Jul 22, 2026 | 8-K | 5.07 | Shareholder vote results | — | Filing |
| Jun 29, 2026 | 8-K | 5.02, 7.01, 9.01 | Director or executive change; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| May 29, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| May 5, 2026 | 8-K | 5.02, 7.01, 9.01 | Director or executive change; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Apr 8, 2026 | 8-K | 1.01, 5.02, 9.01 | Material definitive agreement; Director or executive change; Financial statements / exhibits | — | Filing |
| Mar 27, 2026 | 8-K | 5.02 | Director or executive change | — | Filing |
| Mar 6, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Jan 29, 2026 | 8-K | 5.02, 9.01 | Director or executive change; Financial statements / exhibits | — | Filing |
| Jan 21, 2026 | 8-K | 1.01, 2.03, 9.01 | Material definitive agreement; New direct financial obligation; Financial statements / exhibits | Debt | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Aug 1, 2026 | $529.9M | -3.0% |
| Ended May 2, 2026 | $487.0M | +2.8% |
| Ended Nov 1, 2025 | $616.2M | +3.3% |
| Ended Aug 2, 2025 | $546.0M | +4.0% |
| Period | Revenue | YoY |
|---|---|---|
| Ended Jan 31, 2026 | $2.4B | +4.8% |
| Ended Feb 1, 2025 | $2.3B | +0.0% |
| Ended Feb 3, 2024 | $2.3B | -2.5% |
| Ended Jan 28, 2023 | $2.4B | -1.5% |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Vanguard Group CIK0000102909 | Mar 13, 2026 observed Mar 26, 2026 filed · 13d Schedule 13G amendment | Exit below reporting threshold | 0 -899.1K | 0.00% -8.14 pts | $25.01 | $28.80 | $36.51 |
| Vanguard Group CIK0000102909 | Mar 31, 2025 observed Apr 30, 2025 filed · 30d Schedule 13G amendment | Reported accumulation | 899.1K +235.7K | 8.14% +2.37 pts | $21.23 | $19.40 | $36.51 |
| BlackRock CIK0002012383 | Mar 31, 2025 observed Apr 17, 2025 filed · 17d Schedule 13G amendment | Reported reduction | 858.4K -233.3K | 7.80% -1.90 pts | $21.23 | $19.07 | $36.51 |
Compare GCO with other securities showing similar institutional activity or recent accumulation across several tracked institutions.